Kaplan‐Meier analysis found that higher FEZF1‐AS1 expression was related to adverse clinical pathological parameters as well as poor survival rate, such as lymph node metastasis, higher pathological T stage, invasion and distant metastasis. The gene discussed is FEZF1; the disease is metastatic malignant neoplasm in the lymph nodes.